Retailers Anxiously Await DEA Guidelines On Meth Act, PSE Logbooks
This article was originally published in The Tan Sheet
Executive Summary
Chain drug stores are growing increasingly worried about their ability to implement provisions of the Combat Meth Act before the Sept. 30 deadline as the Drug Enforcement Administration continues to delay issuing its new requirements for sale of pseudoephedrine products, according to NACDS VP-Pharmacy Regulatory Affairs Kevin Nicholson
You may also be interested in...
Wyden To Propose Prescription-Only Status For Pseudoephedrine
Legislation drafted by Sen. Ron Wyden would require prescriptions for all products containing the methamphetamine precursor pseudoephedrine
Wyden To Propose Prescription-Only Status For Pseudoephedrine
Legislation drafted by Sen. Ron Wyden would require prescriptions for all products containing the methamphetamine precursor pseudoephedrine
Wyden To Propose Prescription-Only Status For Pseudoephedrine
Legislation drafted by Sen. Ron Wyden would require prescriptions for all products containing the methamphetamine precursor pseudoephedrine